Mid-Year Report

MONUMENT ADVOCACY for ELI LILLY AND COMPANY

Firm
Client
Income
$33,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

International market access for innovative pharmaceutical products.

LobbyistCovered position, as disclosed
ANDREW HOWELL N/A
ANDREW CHANNING MEEHAN N/A
TIMOTHY PUNKE N/A
RYAN SPANGLER N/A
CHARLES STEWART VERDERY N/A

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Health Issues HCR

H.R. 1567; S. 968; International efforts to curb multi-drug resistant tuberculosis.

LobbyistCovered position, as disclosed
ANDREW HOWELL N/A
ANDREW CHANNING MEEHAN N/A
TIMOTHY PUNKE N/A
RYAN SPANGLER N/A
CHARLES STEWART VERDERY N/A

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: S. 968 (110th), H.R. 1567 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.